PNA5 targets Parkinson’s cognitive symptoms, may slow decline

by Margarida Maia PhD | Nov 27, 2024 | Parkinsons

Mice modeling Parkinson’s disease performed better on tests of memory and spatial recognition when given daily under-the-skin injections of PNA5, an experimental ProNeurogen therapy targeting cognitive symptoms — suggesting the treatment’s potential to slow cognitive